Page 0060

CANCER MANAGEMENT

CANCER CONTROL 2014 59

References

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional

mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic

analysis for the Global Burden of Disease Study. Lancet 380:2095-128.

2. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD et al. (2013) Disability-adjusted

life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic

analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2197-2223.

3. World Health Organization (2008) Global burden of disease: 2004 update. Geneva:

World Health Organization.

4. Bustreo F, Knaul FM, Bhadelia A, Beard J, de Carvalho IA (2012) Women's health

beyond reproduction: meeting the challenges. WHO Bulletin; 90: 478-478A.

5. Knaul FM, Bhadelia A, Gralow J, Arreola-Ornelas H, Langer A, Frenk J (2012) Meeting

the emerging challenge of breast and cervical cancer in low and middle income

countries. Int J Gynaecol Obstet 119:S85-8.

6. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, et al (2011) Breast

and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis.

Lancet 378(9801):1461-84.

7. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, et al. (2010). Maternal mortality

for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium

Development Goal 5. Lancet 375(9726):1609-1623.

8. UN General Assembly. Political declaration of the high-level meeting of the general

assembly on the prevention and control of non-communicable diseases. A/66/L.1. Sept

16, 2011. Available: http://www.un.org.ga.search.view_doc.asp?symbol=A/66/L.1

Accessed 1 March 2013.

9. World Health Organization. Follow-up to the Political Declaration of the High-level

Meeting of the General Assembly on the Prevention and Control of Non-communicable

Disease. Sixty-Sixth World Health Assembly. WHA66.10, May 27, 2013. Availabe:

http://ncdalliance.org/sites/default/files/rfiles/final%20or%20

with%20GAP_A66_r10-en.pdf. Accessed 14 August 2013.

10.alleyne G, Binagwaho A, Haines A, Jahan S, Nugent R, et al. (2013) Embedding noncommunicable diseases in the post-2015 development

agenda. Lancet 381:566-64.

11.bonita R, Magnusson R, Bovet P, Zhao D, Geneau R, et al. (2013) Country actions to

meet UN commitments on non-communicable diseases: a stepwise approach. Lancet

381:575-84.

12.di Cesare M, Khang Y-H, Asaria P, Blakely T, Cowan MJ, et al. (2013) Inequalities in noncommunicable diseases and effective

responses. Lancet 381:585-97.

13.moodie R, Stuckler D, Monteiro C, Sheron N, Neal B, et al. (2013) Profits and

pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food

and drink industries. Lancet 381:670-9.

14.hogerzeil HV, Liverman J, Wirtz VJ, Kishore SP, Selvaraj S, et al. (2013) Promotion of

access to essential medicines for non-communicable diseases: practical implications of

the UN political declaration. Lancet 381:680-9.

15.atun R, Jaffar S, Nishtar S, Knaul FM, Barreto ML, et al. (2013) Improving

responsiveness of health systems to non-communicable diseases. Lancet

381(9867):690-7.

16.farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, et al. (2010) Expansion of cancer

care and control in low and middle income countries: a call to action. Lancet

376(9747):1186-1193.

17.gralow JR, Krakauer E, Anderson BO, Ilbawi A, Porter P, et al. (2012) Chapter 5: Core

elements for provision of cancer care and control in low and middle income countries.

In: Knaul FM, Gralow JR, Atun R, Bhadelia A, editors. Closing the cancer divide: an

equity i1mperative. Cambridge: Harvard University Press. pp. 123-166.

18.knaul FM, Bhadelia A, Bashshur R, Berger AJ, Binagwaho A, et al. (2012) Chapter 6:

Innovative delivery of cancer care and control in low-resource scenarios. In: Knaul FM,

Gralow JR, Atun R, Bhadelia A, editors. Closing the cancer divide: an equity imperative.

Cambridge: Harvard University Press. pp. 169-196.

19.konduri N, Quick J, Gralow JR, Samiei M, Castle P, et al. (2012) Chapter 7: Access to

affordable medicines, vaccines, and health technologies. In: Knaul FM, Gralow JR, Atun

R, Bhadelia A, editors. Closing the cancer divide: an equity imperative. Cambridge:

Harvard University Press. pp. 197-256.

20.knaul FM, Adami H-O, Adebamowo C, Arreola-Orelas A, Berger AJ, et al. (2012)

Chapter 2: The global cancer divide: an equity imperative. In: Knaul FM, Gralow JR,

Atun R, Bhadelia A, editors. Closing the cancer divide: an equity imperative. Cambridge:

Harvard University Press. pp. 29-70.

21.langer A, Frenk J, Horton R (2011) Women and health initiative: integrating needs and

response. Lancet 380(9842):631-2.

22.omran AR (1971) The epidemiological transition: a theory of the epidemiology of

population change. Millbank Q 49(4):509-38.

23.frenk J, Bobadilla JL, Sepúlveda J, Cervantes ML (1989) Health transition in middleincome countries: new challenges for health care. Health

Policy Plan 4(1):29-39.

24.bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according

to the Human Development Index (2008-2030): a population-based study. Lancet

Oncol 13: 790-801

25.el-Serag HB (2007). Epidemiology of hepatocellular carcinoma in USA. Hepatology

Research 37(s2): S88-S94.

26.nelson PK, Mathers BM, Cowie B, Hagan H, Jarlais DD, et al (2011) Global

epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of

systematic reviews. Lancet 378(9791): 13-9.

27.yang JD, Roberts LR (2010). Hepatocellular carcinoma: a global view. Nat Rev

Gastroenterol Hepatol 7(8): 448-58.

28.knaul FM, Frenk J, Shulman L, for the Global Task Force on Expanded Access to Cancer

Care and Control in Developing Countries. Closing the cancer divide: a blueprint to

expand access in low and middle income countries. Boston, MA: Harvard Global Equity

Initiative; October, 2011. Available: http://gtfccc.harvard.edu/icb/icb.do?

keyword=k69586&pageid=icb.page495154

29.López-Carrillo L, Franco-Marina F, Keating N, Arreola-Ornelas H, Knaul FM

(Forthcoming). Breast cancer age at diagnosis patterns in Latin America.

30.directorate General of Health Information (DGIS). Database of general deaths 1979-

2011. [Internet]. Mexico: National System of Health Information (SINAIS), Ministry of

Health. Available: http://www.sinais.salud.gob.mx

31.deprivation index by State and Municipality 2010. Mexico: National Population Council

(CONAPO). [Internet]. Available: http://www.conapo.gob.mx/es/conapo/

Indices_de_Marginacion_2010_por_entidad_federativa_y_municipio

32.loos AH, Bray F, McCarron P, Weiderpass E, Hakama M, et al. (2004) Sheep and goats:

separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for

studies of geographical and temporal variations in mortality. Eur J Cancer 40(18):2794-

803.

33.castellsagué X (2008) Natural history and epidemiology of HPV infection and cervical

cancer. Gynecol oncol 110(3): S4-S7.

34.united Nations Development Programme (2009) Human Development Report 2009:

overcoming barriers-human mobility and development. New York: United Nations.

35.ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, et al (2010) Cancer Incidence in

Five Continents, Volumes I to IX: IARC Cancer Base No. 9. Lyon, France: International

Agency for Research on Cancer. Available: http://ci5.iarc.fr

36.international Agency for Research on Cancer. GLOBOCAN 2008. Cancer incidence,

mortality, and prevalence worldwide in 2008. Available: http://globocan.iarc.fr/

37.knaul FM, G Nigenda, R Lozano, H Arreola-Ornelas, A Langer, et al. (2008) Breast

Cancer in Mexico: a pressing priority. Reprod Health Matters 16(32):113-23.

38.knaul FM, González-Pier E, Gómez-Dantés O, García-Junco D, Arreola-Ornelas H, et al.

(2012) The quest for universal health coverage: Achieving social protection for all in

Mexico. Lancet 380(9849):1259-79.

39.gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the

potential prevention of noncervical cancers in both men and women. Cancer

113(10):3036-46.

40.porter P (2008) "Westernizing" women's risks? Breast cancer in lower-income

countries. N Engl J Med 358:213-6.

41.knaul FM, Gralow JR, Atun R, Bhadelia A, Frenk J, et al. (2012) Chapter 1: Closing the

cancer divide: overview and summary. In: Knaul FM, Gralow JR, Atun R, Bhadelia A,

editors. Closing the cancer divide: an equity imperative. Cambridge: Harvard University

Press. pp. 3-28.

42.newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg R, et al. (1994)

Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330(2):81-

87.

43.mccormack VA, Boffetta P (2011). Today's lifestyles, tomorrow's cancers: trends in

lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol 22:

2349-57.

44.breast Health Global Initiative (2008) Guidelines for International Breast Health and

Cancer Control - Implementation. Cancer 113(Suppl 8):2215-2371.

45.knaul FM, Alleyne G, Atun R, Bustreo F, Gralow JR, et al. (2012) Chapter 10:

Strengthening stewardship and leadership to expand access to cancer care and control.

In: Knaul FM, Gralow JR, Atun R, Bhadelia A, editors. Closing the cancer divide: an

equity imperative. Cambridge: Harvard University Press. pp. p. 311-342.

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066
  67. Page 0067
  68. Page 0068
  69. Page 0069
  70. Page 0070
  71. Page 0071
  72. Page 0072
  73. Page 0073
  74. Page 0074
  75. Page 0075
  76. Page 0076
  77. Page 0077
  78. Page 0078
  79. Page 0079
  80. Page 0080
  81. Page 0081
  82. Page 0082
  83. Page 0083
  84. Page 0084
  85. Page 0085
  86. Page 0086
  87. Page 0087
  88. Page 0088
  89. Page 0089
  90. Page 0090
  91. Page 0091
  92. Page 0092
  93. Page 0093
  94. Page 0094
  95. Page 0095
  96. Page 0096
  97. Page 0097
  98. Page 0098
  99. Page 0099
  100. Page 0100
  101. Page 0101
  102. Page 0102
  103. Page 0103
  104. Page 0104
  105. Page 0105
  106. Page 0106
  107. Page 0107
  108. Page 0108
  109. Page 0109
  110. Page 0110
  111. Page 0111
  112. Page 0112
  113. Page 0113
  114. Page 0114
  115. Page 0115
  116. Page 0116
  117. Page 0117
  118. Page 0118
  119. Page 0119
  120. Page 0120
  121. Page 0121
  122. Page 0122
  123. Page 0123
  124. Page 0124
  125. Page 0125
  126. Page 0126
  127. Page 0127
  128. Page 0128
  129. Page 0129
  130. Page 0130
  131. Page 0131
  132. Page 0132
  133. Page 0133
  134. Page 0134
  135. Page 0135
  136. Page 0136
  137. Page 0137
  138. Page 0138
  139. Page 0139
  140. Page 0140
  141. Page 0141
  142. Page 0142
  143. Page 0143
  144. Page 0144
  145. Page 0145
  146. Page 0146
  147. Page 0147
  148. Page 0148
  149. Page 0149
  150. Page 0150
  151. Page 0151
  152. Page 0152
  153. Page 0153
  154. Page 0154
  155. Page 0155
  156. Page 0156

powered by PageTiger